| Structural insights into the South African HIV-1 subtype C protease: impact of hinge region dynamics and flap flexibility in drug resistance P Naicker, I Achilonu, S Fanucchi, M Fernandes, MAA Ibrahim, HW Dirr, ... Journal of Biomolecular Structure and Dynamics 31 (12), 1370-1380, 2013 | 48 | 2013 |
| Comparison of the molecular dynamics and calculated binding free energies for nine FDA‐approved HIV‐1 PR drugs against subtype B and C‐SA HIV PR SM Ahmed, HG Kruger, T Govender, GEM Maguire, Y Sayed, ... Chemical biology & drug design 81 (2), 208-218, 2013 | 47 | 2013 |
| Zirconium (IV)-IMAC revisited: improved performance and phosphoproteome coverage by magnetic microparticles for phosphopeptide affinity enrichment I Arribas Diez, I Govender, P Naicker, S Stoychev, J Jordaan, ON Jensen Journal of proteome research 20 (1), 453-462, 2020 | 34 | 2020 |
| SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways EE Nweke, P Naicker, S Aron, S Stoychev, J Devar, DL Tabb, ... PLoS One 15 (10), e0240453, 2020 | 15 | 2020 |
| Non-B HIV-1 subtypes in sub-Saharan Africa: impact of subtype on protease inhibitor efficacy P Naicker, Y Sayed Biological Chemistry 395 (10), 1151-1161, 2014 | 15 | 2014 |
| Amide hydrogen exchange in HIV–1 subtype B and C proteases–insights into reduced drug susceptibility and dimer stability P Naicker, S Stoychev, HW Dirr, Y Sayed The FEBS journal 281 (24), 5395-5410, 2014 | 13 | 2014 |
| The forkhead domain hinge-loop plays a pivotal role in DNA binding and transcriptional activity of FOXP2 G Morris, S Stoychev, P Naicker, HW Dirr, S Fanucchi Biological Chemistry 399 (8), 881-893, 2018 | 9 | 2018 |
| Targeting gallbladder cancer: a pathway based perspective P Baichan, P Naicker, JWS Devar, M Smith, GP Candy, E Nweke Molecular Biology Reports 47, 2361-2369, 2020 | 8 | 2020 |
| Mag-Net: Rapid enrichment of membrane-bound particles enables high coverage quantitative analysis of the plasma proteome CC Wu, KA Tsantilas, J Park, D Plubell, JA Sanders, P Naicker, ... bioRxiv, 2023.06. 10.544439, 2023 | 6 | 2023 |
| Protocol for high-throughput semi-automated label-free-or TMT-based phosphoproteome profiling C Koenig, A Martinez-Val, P Naicker, S Stoychev, J Jordaan, JV Olsen STAR protocols 4 (3), 102536, 2023 | 5 | 2023 |
| Proteomic analysis identifies dysregulated proteins and associated molecular pathways in a cohort of gallbladder cancer patients of African ancestry P Baichan, P Naicker, TN Augustine, M Smith, G Candy, J Devar, ... Clinical Proteomics 20 (1), 8, 2023 | 4 | 2023 |
| F99 is critical for dimerization and activation of South African HIV-1 subtype C protease P Naicker, P Seele, HW Dirr, Y Sayed The Protein Journal 32, 560-567, 2013 | 4 | 2013 |
| Universal unbiased sample clean-up pre-mass spectrometry using MagReSyn® HILIC for SPE S Stoychev, I Gerber, J Jordaan, RB Pty, P Naicker, F Khumalo, ... ASMS, 2012 | 4 | 2012 |
| Zirconium (IV)-IMAC for phosphopeptide enrichment in phosphoproteomics IA Diez, I Govender, P Naicker, S Stoychev, J Jordaan, ON Jensen BioRxiv, 2020.04. 13.038810, 2020 | 3 | 2020 |
| Candida parapsilosis Cell Wall Proteome Characterization and Effectiveness against Hematogenously Disseminated Candidiasis in a Murine Model X Gong, V Srivastava, P Naicker, A Khan, A Ahmad Vaccines 11 (3), 674, 2023 | 2 | 2023 |
| Urine-HILIC: Automated sample preparation for bottom-up urinary proteome profiling in clinical proteomics IS Govender, R Mokoena, S Stoychev, P Naicker Proteomes 11 (4), 29, 2023 | 1 | 2023 |
| Inhibition of the Complement Pathway Induces Cellular Proliferation and Migration in Pancreatic Ductal Adenocarcinoma Z Nsingwane, P Naicker, J Omoshoro-Jones, J Devar, M Smith, G Candy, ... JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS 38 (2), 1181-1192, 2024 | | 2024 |
| Assessing the dynamics and macromolecular interactions of the intrinsically disordered protein YY1 H Donald, A Blane, S Buthelezi, P Naicker, S Stoychev, J Majakwara, ... Bioscience Reports 43 (10), 2023 | | 2023 |
| A look at emerging therapeutic targets for gallbladder cancer: A multi-omics approach P Baichan, P Naicker, J Devar, M Smith, EE Nweke Gallbladder Cancer: Current Treatment Options, 161-175, 2023 | | 2023 |
| Inhibition of the Complement Pathway is Implicated in the Induction of Cellular Proliferation and Migration in Pancreatic Ductal Adenocarcinoma Z Nsingwane, P Naicker, J Omoshoro-Jones, J Devar, M Smith, G Candy, ... medRxiv, 2023.08. 08.23293417, 2023 | | 2023 |
